News | May 03, 2021
Gujarat Themis Biosyn Q4FY21 net profit lower at Rs. 5.79 Cr
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
The plant will have installed production capacity of 3,120 MT/month
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
Alkem Medtech to acquire 100% stake of Bombay Ortho
This will lead to the consolidation and optimization of the company's operations related to the manufacturing of ampoules and vials
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
The inspection was successfully completed
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Subscribe To Our Newsletter & Stay Updated
